SAMe supplement to prevent new colon growths
Part of Cancer, Digestive system clinical trials.
This trial tests a dietary supplement called SAMe to see if it can stop new colon polyps from forming in people who had early-stage colon cancer removed. It involves taking the supplement for up to a year and providing stool and biopsy samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had stage I or II colon cancer that was completely removed by surgery.
- You are willing to provide stool samples and small tissue samples from your colon before and after the study.
- You can start the supplement within about a month of the initial biopsy and continue it for up to 12 months.
- You did not receive chemotherapy or radiation after your surgery.
- You are not pregnant or breastfeeding.
- You have not taken high-dose aspirin (over 100 mg per day) in the last 60 days.
- You do not have familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer, or inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a dietary supplement called SAMe can protect the liver from damage caused by oxaliplatin, a chemotherapy drug for colorectal cancer that has spread to the liver. If you are planning to have liver surgery after chemotherapy, this study might help reduce liver side effects.
This study collects body samples to help evaluate tests for people with suspected or newly diagnosed colorectal conditions, often around the time of colonoscopy or surgery. Depending on the arm, you may be asked to have a colonoscopy soon or to provide samples before planned surgery.
This study tests whether an oral synbiotic (a probiotic plus a prebiotic) can reduce the chance that advanced colon growths come back after they were removed. It also looks at changes in stool-related bacterial “gene markers” that may signal lower risk over time.
This trial tests whether taking a probiotic called Clostridium Butyricum after colon polyp removal can lower the chance of polyps coming back. It is looking for people who had adenomas removed and are not already taking certain supplements or antibiotics.
This early-phase trial studies REC-4881 in adults with familial adenomatous polyposis (FAP), a condition that causes many colon/rectum and duodenal polyps. It aims to see whether the treatment can safely help control or shrink polyp growth in people who have had bowel surgery.
This trial tests a drug called ONC201 to see if it can safely help prevent colon polyps from coming back in people at high risk. You will take the drug for about 12 weeks and have a second colonoscopy to check results.
Hear when a new Colorectal Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.